Budesonide Formoterol

DRUG2 trials

Sponsors

The First Affiliated Hospital with Nanjing Medical University, Dr Pinkie Mekgwe

Conditions

Bronchial AsthmaRespiratory

Phase 3

Anti-Inflammatory Reliever therapy for asthma using inhaled budesonide/formoterol as-needed with or without maintenance in South African children: A Pragmatic Open Label Phase 3 Randomised Controlled Trial

RecruitingPACTR202502547023775

Dr Pinkie MekgweRespiratory

Start: 2024-01-02Target: 1038Updated: 2026-09-14

A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)

Not yet recruitingNCT06895460

The First Affiliated Hospital with Nanjing Medical UniversityBronchial Asthma

Start: 2025-06-20End: 2027-09-30Target: 198Updated: 2025-06-05

Related Papers

Anti-inflammatory reliever therapy for asthma using inhaled budesonide/formoterol as-needed with or without maintenance in South African children (AIR-SA 001): a description of a randomised clinical trial protocol.

2025-11-17